questionText: To ask the Secretary of State for Health and Social Care, what progress is being made in replacing plasma-derived products with recombinant coagulation factor products, where clinically appropriate, in accordance with Recommendation 9 of the Infected Blood Inquiry Report.
answerText: It is crucial we protect the safety of haemophilia care, and the Government is committed to implementing recommendation 9 of the 2024 Infected Blood Inquiry report.The Government is committed to improving the lives of those living with rare diseases, such...
heading: Infected Blood Inquiry